TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06608823: ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™

Sponsor: JenaValve Technology, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 1016 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$2,025,200

Rescue Site Savings

+$1,328,000

Unlock Full NCT06608823 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06608823 Rescue Dossier →